(Health-NewsWire.Net, April 05, 2023 ) Maximize Market research expects, the Anti-Obesity Drugs Market to grow from USD 1.68 Bn in 2021 to USD 5.17 Bn in 2029 at a CAGR of 15.1 percent.
Anti-Obesity Drugs Market Report Scope and Research Methodology
The objective of the report is to analyze and forecast the Anti-Obesity Drugs Market size. It also includes drivers, restraints, opportunities and challenges, which helps to understand the current and future market performance. This makes the market report a guide for investors. The report includes the list of top players in the Anti-Obesity Drugs industry.
The increase in the number of obesity and overweight patients due to bad eating habits across the world is expected to drive the Anti-Obesity Drugs Market growth. The lack of combination therapy and the side effects of drugs is hampering the growth of the market.
Anti-Obesity Drugs Market Regional Insights
The Anti-Obesity Drugs Market in the Asia Pacific region is expected to grow at a high rate during the forecast period due to the increasing consumer disposable income and increasing prevalence of obesity.
Maximize Market Research is leading Healthcare research firm, has also published the following reports:
Anti-Obesity Prescription Drugs Market- The market size is expected to reach USD 3.78 billion by 2029 at a CAGR of 4.9 percent during the forecast period.
Addison ’s disease Drugs Market- The market size is expected to reach USD 3.69 billion by 2029 at a CAGR of 7.23 percent during the forecast period.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 6,500 high-growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.